Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
about
FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapyImportance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases.A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases.Recent advances in the curative treatment of colorectal liver metastasesPharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients.Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II studyReceptor-directed therapy of T-cell leukemias and lymphomas.Prospective multicenter phase II clinical trial of FOLFIRI chemotherapy as a neoadjuvant treatment for colorectal cancer with multiple liver metastasesMetastatic colorectal cancer: recent advances in its clinical management.Neoadjuvant therapy of colorectal liver metastases: lessons learned from clinical trials.Optimum chemotherapy regimens for neoadjuvant therapy of hepatic colorectal metastases.Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases.Survival outcome in New Zealand after resection of colorectal cancer lung metastases.A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial.Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort.Laparoscopic two-stage hepatectomy for bilobar colorectal liver metastases.Randomized trial of simplified LV5FU2 versus FOLFOX7 followed by FOLFIRI (MIROX) in patients with initially resectable metastatic colorectal cancer: a GERCOR study.Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: relationships with treatment outcome.Phase II trial alternating FOLFOX-6 and FOLFIRI regimens in second-line therapy of patients with metastatic colorectal cancer (FIREFOX study).Trends in the multimodality treatment of resectable colorectal liver metastases: an underutilized strategy.
P2860
Q26851060-2B68047B-E6CE-4BDA-879F-F69D66B1943FQ33330997-8F3641FD-47F1-46E3-8A0A-03305311FD70Q33448992-DC896B05-457D-47AD-9057-BF2DA7A526D3Q35767565-415D6E8F-65DF-44A1-AC17-334DD5840AE1Q36943988-85271A13-E2BB-49C4-A439-C1CBCA0AF9E0Q37182234-226D325E-52F9-4C70-97A9-9A3859BF684EQ37196716-676D2990-A624-4E38-A9EF-09AE554E667EQ37217358-6AA5DCCD-1EE5-4024-B44D-B3CC2D665AD1Q37642801-E06552BE-4680-468A-861C-8ADD18490FECQ37821842-44D30572-1F15-42E8-B5B2-F9C87E6B2DC3Q37821845-F36F9246-5BC4-4056-BFA1-A1D8C745EFA2Q37969833-EE6282FA-178C-4B4D-B820-C8B93B801727Q38062927-6C32EA6E-A8D2-4804-9E14-5E64DA1316B3Q39365352-DBEDD338-A6E5-4E71-86B8-CF425E643FA0Q40616446-C725F71E-F0B8-469D-AB18-A3C2F4BC29AEQ41336846-BF82FC71-25B7-4127-BD98-968467BF50EAQ43457248-9C56B93C-E9F7-4B3F-9C89-7E1F2A8AB70FQ46845988-BFBC9F13-D160-40A7-B219-CE7A43EE14D2Q46990345-8926331A-D91B-43A6-BEA3-13475EA6954AQ51786105-90DCAEF3-A61A-49CA-8599-424CFDAE81EC
P2860
Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Intensive systemic chemotherap ...... : results of a phase II study.
@ast
Intensive systemic chemotherap ...... : results of a phase II study.
@en
type
label
Intensive systemic chemotherap ...... : results of a phase II study.
@ast
Intensive systemic chemotherap ...... : results of a phase II study.
@en
prefLabel
Intensive systemic chemotherap ...... : results of a phase II study.
@ast
Intensive systemic chemotherap ...... : results of a phase II study.
@en
P2093
P50
P356
P1476
Intensive systemic chemotherap ...... : results of a phase II study.
@en
P2093
Brice Gayet
Christophe Louvet
Christophe Tournigand
François Paye
Frédérique Maindrault Goebel
Mohamed Hebbar
Nathalie Perez
Pascal Artru
Rolland Parc
P304
P356
10.1200/JCO.2005.05.082
P407
P577
2005-01-01T00:00:00Z